INTERVENTION 1:	Intervention	0
Arm 1 - CoQ10 & Vitamin E	Intervention	1
vitamin e	CHEBI:33234	16-25
CoQ10 100mg capsule combined with Vitamin E 100 IU taken orally three times per day.	Intervention	2
capsule	GO:0042603	12-19
vitamin e	CHEBI:33234	34-43
day	UO:0000033	80-83
INTERVENTION 2:	Intervention	3
Arm 2 - Placebo & Vitamin E	Intervention	4
vitamin e	CHEBI:33234	18-27
Placebo-Vitamin E 100 mg/day in 3 doses	Intervention	5
Inclusion Criteria:	Eligibility	0
Signed consent	Eligibility	1
Hg > 11g/dl; supportive measures (erythropoietin, transfusion, iron therapy) should be utilized to assist with maintaining Hgb levels	Eligibility	2
erythropoietin	CHEBI:81579,GO:0005128	34-48
Total cholesterol > 160mg/dL.	Eligibility	3
cholesterol	CHEBI:16113	6-17
Female with primary cancer diagnosis (breast)	Eligibility	4
female	PATO:0000383	0-6
cancer	DOID:162	20-26
breast	UBERON:0000310	38-44
Planned adjuvant chemotherapy (neoadjuvant chemotherapy is excluded)	Eligibility	5
adjuvant	CHEBI:60809	8-16
adjuvant	CHEBI:60809	34-42
excluded	HP:0040285	59-67
KPS > 60	Eligibility	6
Bilirubin < 1.5 x ULN	Eligibility	7
x	LABO:0000148	16-17
SGOT < 2.5 x ULN	Eligibility	8
x	LABO:0000148	11-12
SGPT < 2.5 x ULN	Eligibility	9
x	LABO:0000148	11-12
Exclusion Criteria:	Eligibility	10
Recent involuntary weight loss (> 5% of body weight in the past 3 months)	Eligibility	11
weight loss	HP:0001824	19-30
body weight	CMO:0000012	40-51
Statin therapy - current or planned during study. Below is a list of some commonly used statin drugs.(Note: This is a helpful guide, not a complete list.)	Eligibility	12
statin	CHEBI:87631	0-6
statin	CHEBI:87631	88-94
Atorvastatin (Lipitor)	Eligibility	13
atorvastatin	CHEBI:39548	0-12
Cerivastatin	Eligibility	14
cerivastatin	CHEBI:3558	0-12
Fluvastatin (Lescol)	Eligibility	15
fluvastatin	CHEBI:38561	0-11
Lovastatin (Mevacor, Altocor, Advicor)	Eligibility	16
lovastatin	CHEBI:40303	0-10
Mevastatin	Eligibility	17
mevastatin	CHEBI:34848	0-10
Pravastatin (Pravachol)	Eligibility	18
pravastatin	CHEBI:63618	0-11
Rosuvastatin	Eligibility	19
rosuvastatin	CHEBI:38545	0-12
Simvastatin (Zocor)	Eligibility	20
simvastatin	CHEBI:9150	0-11
Current or planned use of the following medications for fatigue	Eligibility	21
fatigue	HP:0012378	56-63
Corticosteroids (intermittent use as part of chemotherapy regimen is allowed)	Eligibility	22
part of	BAO:0090002,BFO:0000050	37-44
Amphetamines or other stimulants including methylphenidate (Ritalin)or modafinil (Provigil)	Eligibility	23
amphetamines	CHEBI:35338	0-12
methylphenidate	CHEBI:6887	43-58
modafinil	CHEBI:31859	71-80
Patients diagnosed with uncontrolled hypertension	Eligibility	24
hypertension	HP:0000822,DOID:10763	37-49
Breast cancer patients who are male	Eligibility	25
breast cancer	DOID:1612	0-13
male	CHEBI:30780,PATO:0000384	31-35
Pregnant women are excluded from participation in this study. A Serum pregnancy test is required within 1 week of registration if the patient is a woman of childbearing potential.	Eligibility	26
excluded	HP:0040285	19-27
week	UO:0000034	106-110
patient	HADO:0000008,OAE:0001817	134-141
Anticoagulant therapy - current or planned during study (except for maintenance of catheter patency)	Eligibility	27
anticoagulant	CHEBI:50249	0-13
Patients with uncontrolled thyroid dysfunction	Eligibility	28
Outcome Measurement:	Results	0
Effects of Coenzyme Q10 on Fatigue (as Measured by POMS-F) 24 Weeks Following Randomization	Results	1
coenzyme q10	CHEBI:46245	11-23
fatigue	HP:0012378	27-34
POMS-F is the Profile of Mood States - fatigue scale. It ranges from 0 to 28; higher values indicate greater fatigue.	Results	2
fatigue	HP:0012378	39-46
fatigue	HP:0012378	109-116
Time frame: 24 weeks	Results	3
time	PATO:0000165	0-4
Results 1:	Results	4
Arm/Group Title: Arm 1 - CoQ10 & Vitamin E	Results	5
vitamin e	CHEBI:33234	33-42
Arm/Group Description: CoQ10 100mg capsule combined with Vitamin E 100 IU taken orally three times per day.	Results	6
capsule	GO:0042603	35-42
vitamin e	CHEBI:33234	57-66
day	UO:0000033	103-106
Overall Number of Participants Analyzed: 122	Results	7
Least Squares Mean (Standard Error)	Results	8
mean	BAO:0002173	14-18
Unit of Measure: units on a scale  6.96         (0.71)	Results	9
Results 2:	Results	10
Arm/Group Title: Arm 2 - Placebo & Vitamin E	Results	11
vitamin e	CHEBI:33234	35-44
Arm/Group Description: Placebo-Vitamin E 100 mg/day in 3 doses	Results	12
Overall Number of Participants Analyzed: 114	Results	13
Least Squares Mean (Standard Error)	Results	14
mean	BAO:0002173	14-18
Unit of Measure: units on a scale  8.33         (0.79)	Results	15
Adverse Events 1:	Adverse Events	0
Total: 22/100 (22.00%)	Adverse Events	1
ANC 11/100 (11.00%)	Adverse Events	2
WBC 4/100 (4.00%)	Adverse Events	3
anemia 1/100 (1.00%)	Adverse Events	4
anemia	HP:0001903,DOID:2355	0-6
hypotension 1/100 (1.00%)	Adverse Events	5
hypotension	HP:0002615	0-11
L vent sy d 0/100 (0.00%)	Adverse Events	6
chest pain 0/100 (0.00%)	Adverse Events	7
chest pain	HP:0100749	0-10
constipation 1/100 (1.00%)	Adverse Events	8
constipation	HP:0002019,DOID:2089	0-12
diarrhea 3/100 (3.00%)	Adverse Events	9
diarrhea	HP:0002014,DOID:13250	0-8
ileus 1/100 (1.00%)	Adverse Events	10
ileus	HP:0002595,DOID:8440	0-5
vomiting 1/100 (1.00%)	Adverse Events	11
vomiting	HP:0002013	0-8
abd pain 0/100 (0.00%)	Adverse Events	12
pain	HP:0012531	4-8
nausea 1/100 (1.00%)	Adverse Events	13
nausea	HP:0002018	0-6
allergic reaction 1/100 (1.00%)	Adverse Events	14
fatigue 1/100 (1.00%)	Adverse Events	15
fatigue	HP:0012378	0-7
Adverse Events 2:	Adverse Events	16
Total: 15/93 (16.13%)	Adverse Events	17
ANC 4/93 (4.30%)	Adverse Events	18
WBC 2/93 (2.15%)	Adverse Events	19
anemia 0/93 (0.00%)	Adverse Events	20
anemia	HP:0001903,DOID:2355	0-6
hypotension 0/93 (0.00%)	Adverse Events	21
hypotension	HP:0002615	0-11
L vent sy d 1/93 (1.08%)	Adverse Events	22
chest pain 1/93 (1.08%)	Adverse Events	23
chest pain	HP:0100749	0-10
constipation 1/93 (1.08%)	Adverse Events	24
constipation	HP:0002019,DOID:2089	0-12
diarrhea 2/93 (2.15%)	Adverse Events	25
diarrhea	HP:0002014,DOID:13250	0-8
ileus 0/93 (0.00%)	Adverse Events	26
ileus	HP:0002595,DOID:8440	0-5
vomiting 1/93 (1.08%)	Adverse Events	27
vomiting	HP:0002013	0-8
abd pain 1/93 (1.08%)	Adverse Events	28
pain	HP:0012531	4-8
nausea 3/93 (3.23%)	Adverse Events	29
nausea	HP:0002018	0-6
allergic reaction 0/93 (0.00%)	Adverse Events	30
fatigue 3/93 (3.23%)	Adverse Events	31
fatigue	HP:0012378	0-7
fever 1/93 (1.08%)	Adverse Events	32
fever	HP:0001945	0-5
